Cyril Amarchand Mangaldas advised Motilal Oswal Financial Services Limited and Lead Managers on the deal. Motilal Oswal Financial Services Limited and Lead Managers secured the issuance...
Motilal Oswal Financial’s Non-convertible Debentures Issuance
Eris Lifesciences’ Acquisition of a Stake in Swiss Parenterals
Cyril Amarchand Mangaldas advised Swiss Parenterals Limited on the deal. Eris Lifesciences Limited, an Indian branded formulations company, acquired 51% equity stake in Swiss Parenterals Limited ,...
Five Star Business Finance’s Issuance of NCDs
Cyril Amarchand Mangaldas (CAM) advised Five-Star Business Finance Limited on the deal. Five-Star Business Finance Limited (Five Star) completed the issuance of senior, secured, unsubordinated, rated,...
Titan’s NCD Offering
Cyril Amarchand Mangaldas advised Titan Company Limited on the deal. Titan Company Limited (Titan) completed the issuance of listed, unsecured, rated, redeemable, non-cumulative, non-convertible debentures (NCDs),...
Navi Finserv’s NCDs Offering
Cyril Amarchand Mangaldas advised Navi Finserv Limited on the transaction. Navi Finserv Limited issued secured, rated, listed redeemable NCDs under the Securities and Exchange Board of India (Issue...